Giant Gene Banks Take on Disease
By Erika Check Hayden,
Nature
| 10. 14. 2014
Early last year, three researchers set out to create one genetic data set to rule them all. The trio wanted to assemble the world’s most comprehensive catalogue of human genetic variation, a single reference database that would be useful to researchers hunting rare disease-causing genetic variants.
Unlike past ‘big data’ projects, which have involved large groups of scientists, this one deliberately kept itself small, deploying just five analysts. Nearly two years in, it has identified about 50 million genetic variants — points at which one person’s DNA differs from another’s — in whole-genome sequence data collected by 23 other research collaborations. The group, called the Haplotype Reference Consortium, will unveil its database in San Diego, California, on 20 October, at the annual meeting of the American Society of Human Genetics.
Geneticists have not always been so willing to share data. But that seems to be changing. “It’s been surprisingly easy to bring all these data sets together,” says Jonathan Marchini, a statistical geneticist at the University of Oxford, UK, and one of the consortium’s leaders. “There is a lot of...
Related Articles
By Josie Ensor, The Times | 12.09.2025
A fertility start-up that promises to screen embryos to give would-be parents their “best baby” has come under fire for a “misuse of science”.
Nucleus Genomics describes its mission as “IVF for genetic optimisation”, offering advanced embryo testing that allows...
By Hannah Devlin, The Guardian | 12.06.2025
Couples undergoing IVF in the UK are exploiting an apparent legal loophole to rank their embryos based on genetic predictions of IQ, height and health, the Guardian has learned.
The controversial screening technique, which scores embryos based on their DNA...
By Frankie Fattorini, Pharmaceutical Technology | 12.02.2025
Próspera, a charter city on Roatán island in Honduras, hosts two biotechs working to combat ageing through gene therapy, as the organisation behind the city advertises its “flexible” regulatory jurisdiction to attract more developers.
In 2021, Minicircle set up a...
By Vardit Ravitsky, The Hastings Center | 12.04.2025
Embryo testing is advancing fast—but how far is too far? How and where do we draw the line between preventing disease and selecting for “desirable” traits? What are the ethical implications for parents, children, clinicians, and society at large? These...